PMID- 30679557 OWN - NLM STAT- MEDLINE DCOM- 20200810 LR - 20211204 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 9 IP - 1 DP - 2019 Jan 24 TI - Marine biogenics in sea spray aerosols interact with the mTOR signaling pathway. PG - 675 LID - 10.1038/s41598-018-36866-3 [doi] LID - 675 AB - Sea spray aerosols (SSAs) have profound effects on our climate and ecosystems. They also contain microbiota and biogenic molecules which could affect human health. Yet the exposure and effects of SSAs on human health remain poorly studied. Here, we exposed human lung cancer cells to extracts of a natural sea spray aerosol collected at the seashore in Belgium, a laboratory-generated SSA, the marine algal toxin homoyessotoxin and a chemical inhibitor of the mammalian target of rapamycin (mTOR) pathway. We observed significant increased expression of genes related to the mTOR pathway and Proprotein convertase subtilisin/kexin type 9 (PCSK9) after exposure to homoyessotoxin and the laboratory-generated SSA. In contrast, we observed a significant decrease in gene expression in the mTOR pathway and of PCSK9 after exposure to the natural SSA and the mTOR inhibitor, suggesting induction of apoptosis. Our results indicate that marine biogenics in SSAs interact with PCSK9 and the mTOR pathway and can be used in new potential pharmaceutical applications. Overall, our results provide a substantial molecular evidence base for potential beneficial health effects at environmentally relevant concentrations of natural SSAs. FAU - Asselman, Jana AU - Asselman J AUID- ORCID: 0000-0003-0185-6516 AD - Laboratory of Environmental Toxicology and Aquatic Ecology, Environmental Toxicology Unit - GhEnToxLab, Ghent University, Campus Coupure, Coupure Links 653, Building F - 2nd Floor, Ghent, Belgium. Jana.Asselman@UGent.be. FAU - Van Acker, Emmanuel AU - Van Acker E AD - Laboratory of Environmental Toxicology and Aquatic Ecology, Environmental Toxicology Unit - GhEnToxLab, Ghent University, Campus Coupure, Coupure Links 653, Building F - 2nd Floor, Ghent, Belgium. Emmanuel.VanAcker@UGent.be. FAU - De Rijcke, Maarten AU - De Rijcke M AD - Flanders Marine Institute (VLIZ), InnovOcean site, Wandelaarkaai 7, 8400, Ostend, Belgium. FAU - Tilleman, Laurentijn AU - Tilleman L AUID- ORCID: 0000-0001-7584-1179 AD - Laboratory for Pharmaceutical Biotechnology, Faculty of Pharmaceutical Sciences, Ghent University, Campus UZ, Ottergemse Steenweg 460, 9000, Ghent, Belgium. FAU - Van Nieuwerburgh, Filip AU - Van Nieuwerburgh F AUID- ORCID: 0000-0001-8815-5485 AD - Laboratory for Pharmaceutical Biotechnology, Faculty of Pharmaceutical Sciences, Ghent University, Campus UZ, Ottergemse Steenweg 460, 9000, Ghent, Belgium. FAU - Mees, Jan AU - Mees J AD - Flanders Marine Institute (VLIZ), InnovOcean site, Wandelaarkaai 7, 8400, Ostend, Belgium. FAU - De Schamphelaere, Karel A C AU - De Schamphelaere KAC AD - Laboratory of Environmental Toxicology and Aquatic Ecology, Environmental Toxicology Unit - GhEnToxLab, Ghent University, Campus Coupure, Coupure Links 653, Building F - 2nd Floor, Ghent, Belgium. FAU - Janssen, Colin R AU - Janssen CR AD - Laboratory of Environmental Toxicology and Aquatic Ecology, Environmental Toxicology Unit - GhEnToxLab, Ghent University, Campus Coupure, Coupure Links 653, Building F - 2nd Floor, Ghent, Belgium. LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20190124 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - 0 (41a-homoyessotoxin) RN - 0 (Aerosols) RN - 0 (Oxocins) RN - EC 2.7.1.1 (MTOR protein, human) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - EC 3.4.21.- (PCSK9 protein, human) RN - EC 3.4.21.- (Proprotein Convertase 9) SB - IM MH - A549 Cells MH - Aerosols/*chemistry/*pharmacology MH - Belgium MH - Dinoflagellida/chemistry MH - Gene Expression Regulation, Neoplastic/*drug effects MH - Humans MH - Oceans and Seas MH - Oxocins/*pharmacology MH - Proprotein Convertase 9/genetics MH - Seawater/chemistry MH - TOR Serine-Threonine Kinases/*metabolism PMC - PMC6345880 COIS- The authors declare no competing interests. EDAT- 2019/01/27 06:00 MHDA- 2020/08/11 06:00 PMCR- 2019/01/24 CRDT- 2019/01/26 06:00 PHST- 2018/06/19 00:00 [received] PHST- 2018/11/25 00:00 [accepted] PHST- 2019/01/26 06:00 [entrez] PHST- 2019/01/27 06:00 [pubmed] PHST- 2020/08/11 06:00 [medline] PHST- 2019/01/24 00:00 [pmc-release] AID - 10.1038/s41598-018-36866-3 [pii] AID - 36866 [pii] AID - 10.1038/s41598-018-36866-3 [doi] PST - epublish SO - Sci Rep. 2019 Jan 24;9(1):675. doi: 10.1038/s41598-018-36866-3.